Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Behar

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
JACC. Clinical Electrophysiology|September 21, 2019
A Novel Quadripolar Active Fixation Left-Ventricular Pacing Lead for Cardiac Resynchronization Therapy: Initial United Kingdom ExperienceMichael Chapman, Matthew G D Bates, Jonathan M Behar, et al.
Computers in Biology and Medicine|October 1, 2021
Non-invasive simulated electrical and measured mechanical indices predict response to cardiac resynchronization therapyAngela W C Lee, Orod Razeghi, Jose Alonso Solis-Lemus, et al.
Heart (British Cardiac Society)|October 4, 2017
Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator changeSimon Claridge, Frederic A Sebag, Steven Fearn, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2015
Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter RegistryJonathan M Behar, Julian Bostock, Adrian Po Zhu Li, et al.
Journal of Clinical Medicine|October 14, 2023
Antiplatelet and Anti-Coagulation Therapy for Left-Sided Catheter Ablations: What Is beyond Atrial Fibrillation?Martina Nesti, Fabiana Lucà, David Duncker, et al.
Journal of Cardiovascular Electrophysiology|May 10, 2017
Substrate-dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patientsSimon Claridge, Silvia Mennuni, Thomas Jackson, et al.
Heart Rhythm|May 9, 2017
Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapyJonathan M Behar, Ronak Rajani, Amir Pourmorteza, et al.
Journal of Cardiovascular Electrophysiology|November 26, 2016
Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization TherapyAngela W C Lee, Andrew Crozier, Eoin R Hyde, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Real-Time X-MRI-Guided Left Ventricular Lead Implantation for Targeted Delivery of Cardiac Resynchronization TherapyJonathan M Behar, Peter Mountney, Daniel Toth, et al.
Pacing and Clinical Electrophysiology : PACE|January 19, 2022
The long-term outcomes of cardiac implantable electronic devices implanted via the femoral routeSamuel Griffiths, Jonathan M Behar, Daniel B Kramer, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
JACC. Clinical Electrophysiology|September 21, 2019
A Novel Quadripolar Active Fixation Left-Ventricular Pacing Lead for Cardiac Resynchronization Therapy: Initial United Kingdom ExperienceMichael Chapman, Matthew G D Bates, Jonathan M Behar, et al.
Computers in Biology and Medicine|October 1, 2021
Non-invasive simulated electrical and measured mechanical indices predict response to cardiac resynchronization therapyAngela W C Lee, Orod Razeghi, Jose Alonso Solis-Lemus, et al.
Heart (British Cardiac Society)|October 4, 2017
Cost-effectiveness of a risk-stratified approach to cardiac resynchronisation therapy defibrillators (high versus low) at the time of generator changeSimon Claridge, Frederic A Sebag, Steven Fearn, et al.
Journal of Cardiovascular Electrophysiology|January 30, 2015
Cardiac Resynchronization Therapy Delivered Via a Multipolar Left Ventricular Lead is Associated with Reduced Mortality and Elimination of Phrenic Nerve Stimulation: Long-Term Follow-Up from a Multicenter RegistryJonathan M Behar, Julian Bostock, Adrian Po Zhu Li, et al.
Journal of Clinical Medicine|October 14, 2023
Antiplatelet and Anti-Coagulation Therapy for Left-Sided Catheter Ablations: What Is beyond Atrial Fibrillation?Martina Nesti, Fabiana Lucà, David Duncker, et al.
Journal of Cardiovascular Electrophysiology|May 10, 2017
Substrate-dependent risk stratification for implantable cardioverter defibrillator therapies using cardiac magnetic resonance imaging: The importance of T1 mapping in nonischemic patientsSimon Claridge, Silvia Mennuni, Thomas Jackson, et al.
Heart Rhythm|May 9, 2017
Comprehensive use of cardiac computed tomography to guide left ventricular lead placement in cardiac resynchronization therapyJonathan M Behar, Ronak Rajani, Amir Pourmorteza, et al.
Journal of Cardiovascular Electrophysiology|November 26, 2016
Biophysical Modeling to Determine the Optimization of Left Ventricular Pacing Site and AV/VV Delays in the Acute and Chronic Phase of Cardiac Resynchronization TherapyAngela W C Lee, Andrew Crozier, Eoin R Hyde, et al.
JACC. Clinical Electrophysiology|May 16, 2018
Real-Time X-MRI-Guided Left Ventricular Lead Implantation for Targeted Delivery of Cardiac Resynchronization TherapyJonathan M Behar, Peter Mountney, Daniel Toth, et al.
Pacing and Clinical Electrophysiology : PACE|January 19, 2022
The long-term outcomes of cardiac implantable electronic devices implanted via the femoral routeSamuel Griffiths, Jonathan M Behar, Daniel B Kramer, et al.
Pageof 9